Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

VEGFR

VEGFR are receptors for vascular endothelial growth factor and belong to receptor tyrosine kinases.

Items 1-10 of 55

Page
per page
  1. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  2. Pazopanib (GW-786034)
    A3022 Pazopanib (GW-786034)
    Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥10.95 mg/mL
  3. Regorafenib hydrochloride
    A3750 Regorafenib hydrochloride
    Target: Raf|VEGFR|PDGFR|c-Kit|c-RET
    Summary: Tyrosine kinase inhibitor
      ≥25.95 mg/mL
  4. Regorafenib monohydrate
    A3751 Regorafenib monohydrate
    Summary: Tyrosine kinase inhibitor
      ≥25.05 mg/mL
  5. SU 5402
    A3843 SU 5402
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR2/FGFR/PDGFR/EGFR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.8 mg/mL
  6. SU14813 maleate
    A3846 SU14813 maleate
    Summary: VEGFR/PDGFR/Kit/FLT-3 inhibitor
      Soluble in DMSO
  7. SU5416
    A3847 SU5416
    Target: VEGFR
    Summary: VEGF receptor inhibitor and AHR agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  8. TG 100801
    A3870 TG 100801
    Target: VEGFR|FGFR|Src|Fyn kinase
    Summary: Multi-kinase inhibitor
      Soluble in DMSO
  9. Vandetanib hydrochloride
    A3906 Vandetanib hydrochloride
    Summary: VEGFR/EGFR inhibitor
      ≥51.2 mg/mL
  10. Vatalanib
    A3969 Vatalanib
     1 Citation
    Target: VEGFR
    Summary: VEGFR-1/-2 inhibitor,cell-permeable
      ≥16.85 mg/mL

Items 1-10 of 55

Page
per page